Integra LifeSciences
IART
194 hedge funds and large institutions have $2.2B invested in Integra LifeSciences in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 88 increasing their positions, 62 reducing their positions, and 12 closing their positions.
75% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 12
42% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 62
4% more funds holding
Funds holding: 186 → 194 (+8)
4% more capital invested
Capital invested by funds: $2.12B → $2.2B (+$77M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$25.4M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$18.1M |
| 3 |
Bank of New York Mellon
New York
|
+$16.5M |
| 4 |
BJCM
Blue Jay Capital Management
Los Angeles,
California
|
+$11.2M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$9.81M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAM
201
Aureus Asset Management
Boston,
Massachusetts
| – | -$203K | -6,000 | Closed |
|
202
Fifth Third Bancorp
Cincinnati,
Ohio
| – | -$12K | -362 | Closed |
|
|
IA
203
IFP Advisors
Tampa,
Florida
| – | -$6K | -180 | Closed |
|
|
KCPG
204
Kavar Capital Partners Group
Leawood,
Kansas
| – | -$1K | -52 | Closed |
|
|
QI
205
QS Investors
New York
| – | -$1K | -8 | Closed |
|
IART Hedge Fund Activity: Q1 2016 in Review
194 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2016, worth a combined $2.2B — up 3.6% from $2.12B a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new IART positions and 12 closed out — a net gain of 9 holders — while 88 added to existing stakes and 62 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $51.5M.
- 194 institutional investors held Integra LifeSciences (IART) as of Q1 2016, up from 186 in Q4 2015.
- Funds reported $2.2B of Integra LifeSciences stock for Q1 2016, up 3.6% quarter-over-quarter.
- 21 funds opened new Integra LifeSciences positions in Q1 2016 and 12 closed out, a net change of +9 holders.
- The largest Integra LifeSciences buyer in Q1 2016 was Lord, Abbett & Co, an estimated $25.4M added.
- The largest Integra LifeSciences seller in Q1 2016 was Fidelity Investments, an estimated $51.5M sold.
Based on aggregated 13F filings for Q1 2016.